Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Neuro-Oncology

• Publication date

  2012-07-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11060-012-0925-1PMID 22821382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IDH1 Mutation in Pediatric Gliomas: Has it a Diagnostic and Prognostic Value?

  2012cited by this paper
• Single-Copy Gain of Chromosome 1q Is a Negative Prognostic Marker in Pediatric Nonependymal, Nonpilocytic Gliomas

  2011cited by this paper
• Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

  2011cited by this paper
• Expression of mutated isocitrate dehydrogenase-1 in gliomas is associated with p53 and EGFR expression.

  2011cited by this paper
• Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.

  2010cited by this paper
• A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas

  2010cited by this paper
• Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

  2010cited by this paper
• IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group

  2010cited by this paper
• Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

  2010cited by this paper
• Epidemiology of childhood cancer.

  2010cited by this paper
• A pyrosequencing-based assay for the rapid detection of IDH1 mutations in clinical samples.

  2010cited by this paper
• Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

  2009cited by this paper
• Histology and Molecular Pathology of Pediatric Brain Tumors

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma

  2009cited by this paper
• Mutant metabolic enzymes are at the origin of gliomas.

  2009cited by this paper
• Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

  2009cited by this paper
• IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors

  2009cited by this paper
• IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.

  2009cited by this paper
• IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.

  2009cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2009cited by this paper
• IDH 1 and IDH 2 Mutations in Gliomas

  2009cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Analysis of the IDH1 codon 132 mutation in brain tumors

  2008cited by this paper
• WHO classification of tumours of the central nervous system

  2007cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Malignant Glioma as a Secondary Malignant Neoplasm after Radiation Therapy for Craniopharyngioma. Report of a Case and Review of Reported Cases

  2001cited by this paper
• Arrayed Primer Extension: Solid-Phase Four-Color DNA Resequencing and Mutation Detection Technology

  2000cited by this paper
• Molecular genetic alterations in radiation-induced astrocytomas.

  1999cited by this paper
• [A case of paraventricular anaplastic astrocytoma following radiation therapy for craniopharyngioma].

  1994cited by this paper

• Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis

  2021cites this paper
• Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology

  2020cites this paper
• A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma

  2020cites this paper
• Radiation-induced gliomas: a comprehensive review and meta-analysis

  2018cites this paper
• Erratum to: Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas

  2017cites this paper
• Radiation-induced gliomas: a report of four cases and analysis of molecular biomarkers

  2017cites this paper
• TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma

  2016cites this paper
• Distinctive Genetic Profile With IDH1, TP53, and MLH1 Mutations in a Radiation‐Induced Anaplastic Astrocytoma

  2016cites this paper
• Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

  2015cites this paper
• Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019

  2015cites this paper
• Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas

  2014cites this paper
• The expression of Wnt-1 inducible signaling pathway protein-2 in astrocytoma: Correlation between pathological grade and clinical outcome

  2014cites this paper
• IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma

  2014cites this paper